Smoking Cessation Market

Dec 08, 2020

10 likes | 14 Views

Smoking Cessation is the process of discontinuing tobacco smoking. When a person smokes tobacco in cigarettes, cigars or pipes, they absorb toxins that can lead to various health problems such as diabetes, cancer, chronic obstructive pulmonary disease (COPD), heart diseases, lung diseases, and others. The total diagnosed prevalent population of Smoking Cessation in the 7MM was 49,301,950 in 2017. The diagnosed prevalent cases of smokers in the United Kingdom was found to be 7,750,777 while Germany and France had 19,305,099 and 14,044,812 diagnosed prevalent cases respectively in 2017. As per the Delveinsight, the market size of Smoking Cessation in the 7MM was found to be USD 2,874.8 million in 2017, which is expected to increase during the forecast period. Increase in awareness, government-mandated warnings on tobacco products, research and development are some of the key drivers for Smoking Cessation market. The key companies in the Smoking Cessation Market include Axsome Therapeutics, Achieve Life Sciences, Chronic Airway Therapeutics, Smoke Free Therapeutics (NFL Biosciences SAS), Novo Nordisk and many others. For more details, visit: https://www.delveinsight.com/report-store/smoking-cessation-market Source: Smoking Cessation Market Landscape

DelveInsight

Download Presentation

Smoking Cessation Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D